| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
CTO Pierre Craen Presents and Company Will Demonstrate TLens® and TWedge® in Booth # 5336 HORTEN, Norway, Dec. 6, 2023 /PRNewswire/ -- poLight ASA (OSE: PLT) announced that Chief Technology Officer
-
Dec 6, 2023Virtual Press Office and PR Newswire: General Trade show news
Wei Xue, Vice President of TCL Technology and Chairman of the TCL Charity Foundation, represented the company as a keynote speaker at a side event on 4 December, focused on the role of sustainable...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
SystImmune, Inc (SystImmune), a clinical-stage biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) authorized the company to proceed with the planned clinical...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
BetMGM, LLC ("BetMGM"), one of the leading sports betting and iGaming operators across the U.S., jointly owned by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and Entain plc (LSE: ENT)...
-
Dec 5, 2023Virtual Press Office and PR Newswire: General Trade show news
Company Today Also Provided Updates on R&D Portfolio and Strategy at Investor Event Crinecerfont New Drug Application Submission Planned in 2024 NBI-'770, an Oral NMDA NR2B Negative Allosteric...
